| |
| |
|
| Insider
Information: |
Duyk Geoffrey M |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
83,400 |
|
|
Indirect Shares
|
981,907 |
|
|
| Direct
Value |
$51,930 |
|
|
|
Indirect Value
|
$22,310,154 |
|
|
| Total
Shares |
1,065,307 |
|
|
| Total
Value |
$22,362,084 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Pres R&D & CSO, Director |
2003-09-18 |
0 |
2003-11-04 |
941,355 |
Premium* |
|
|
Amyris, Inc. |
AMRS |
Director |
2023-01-03 |
80,000 |
2023-01-03 |
40,552 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
Director |
2017-02-15 |
3,400 |
2015-04-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMRS |
Amyris, Inc. |
Director |
– • – |
2023-01-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,437 |
40,552 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2023-01-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,437 |
80,000 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-08-22 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
97,154 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
40,552 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2021-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,409 |
30,807 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2020-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,566 |
23,398 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2019-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,566 |
13,832 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2017-02-15 |
4 |
S |
$46.81 |
$973,438 |
D/D |
(20,796) |
3,400 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2017-02-14 |
4 |
S |
$46.46 |
$966,059 |
D/D |
(20,795) |
24,196 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2017-02-14 |
4 |
D |
$46.95 |
$778,243 |
D/D |
(16,576) |
44,991 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2017-02-14 |
4 |
OE |
$3.15 |
$778,132 |
D/D |
58,167 |
46,870 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2016-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
64,000 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
29,000 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
3,400 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2015-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
12,000 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2015-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
1,700 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2014-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,000 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2013-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,000 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2012-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres R&D & CSO |
• • – |
2003-11-04 |
4 |
S |
$7.73 |
$23,971 |
I/I |
(3,101) |
941,355 |
|
- |
|
| EXEL |
Exelixis Inc |
Pres R&D & CSO |
• • – |
2003-10-31 |
4 |
S |
$7.73 |
$23,190 |
I/I |
(3,000) |
944,456 |
|
- |
|
| EXEL |
Exelixis Inc |
Pres R&D & CSO |
• • – |
2003-10-13 |
4 |
S |
$7.90 |
$31,717 |
I/I |
(4,000) |
947,456 |
|
- |
|
| EXEL |
Exelixis Inc |
Pres R&D & CSO |
• • – |
2003-10-09 |
4 |
S |
$7.90 |
$39,555 |
I/I |
(5,000) |
951,456 |
|
- |
|
| EXEL |
Exelixis Inc |
Pres R&D & CSO |
• • – |
2003-10-07 |
4 |
S |
$7.85 |
$39,283 |
I/I |
(5,000) |
956,456 |
|
- |
|
| EXEL |
Exelixis Inc |
Pres R&D & CSO |
• • – |
2003-10-03 |
4 |
S |
$7.95 |
$23,850 |
I/I |
(3,000) |
961,456 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
